Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

Cash Flow Statement 

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Elevance Health Inc., consolidated cash flow statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income 5,991 6,019 6,095 4,572 4,807
Net (gains) losses on financial instruments 694 550 (318) (182) (67)
Equity in net (earnings) losses of other invested assets 33 (293) (562) (51) (93)
Depreciation and amortization 1,745 1,675 1,302 1,154 1,133
Deferred income taxes (602) (76) 326 (540) 81
Impairment of property and equipment 446 7 73 198
Share-based compensation 289 264 255 283 294
Receivables, net (1,762) (2,510) (2,138) (256) (1,053)
Other invested assets (79) 11 (70) (32) (48)
Other assets (675) 120 37 (283) (170)
Policy liabilities 147 2,254 2,597 3,528 1,826
Unearned income 290 (42) (113) 202 115
Accounts payable and other liabilities 1,640 824 719 1,978 (445)
Income taxes (103) (338) 140 72 (325)
Other, net 7 (66) 21 45 6
Changes in operating assets and liabilities (535) 253 1,193 5,254 (94)
Adjustments to reconcile net income to net cash provided by operating activities 2,070 2,380 2,269 6,116 1,254
Net cash provided by operating activities 8,061 8,399 8,364 10,688 6,061
Purchases of investments (16,236) (24,946) (18,669) (19,492) (22,954)
Proceeds from sale of investments 10,596 11,988 10,269 11,318 18,598
Maturities, calls and redemptions from investments 2,940 10,620 4,344 4,741 2,437
Changes in securities lending collateral 78 (301) (956) (849) 254
Purchases of subsidiaries, net of cash acquired (1,552) (649) (3,476) (1,976)
Purchases of property and equipment (1,296) (1,152) (1,087) (1,021) (1,077)
Other, net (102) (120) (63) (45) (50)
Net cash used in investing activities (5,572) (4,560) (9,638) (7,324) (2,792)
Proceeds from long-term borrowings 2,574 3,071 3,462 2,484 2,473
Repayments of long-term borrowings (1,909) (1,899) (1,068) (1,932) (1,123)
Proceeds from short-term borrowings 225 1,365 1,375 970 7,590
Repayments of short-term borrowings (265) (1,675) (1,050) (1,820) (8,332)
Changes in securities lending payable (77) 302 956 849 (254)
Changes in bank overdrafts 114 933 (376) 486
Repurchase and retirement of common stock (2,676) (2,316) (1,900) (2,700) (1,701)
Cash dividends (1,395) (1,229) (1,104) (954) (818)
Proceeds from issuance of common stock under employee stock plans 152 182 203 176 187
Taxes paid through withholding of common stock under employee stock plans (99) (93) (102) (128) (84)
Other, net 7 41 27 2 (204)
Net cash provided by (used in) financing activities (3,349) (1,318) 423 (2,567) (2,266)
Effect of foreign exchange rates on cash and cash equivalents (1) (14) (10) 7
Change in cash and cash equivalents (861) 2,507 (861) 804 1,003
Cash and cash equivalents at beginning of year 7,387 4,880 5,741 4,937 3,934
Cash and cash equivalents at end of year 6,526 7,387 4,880 5,741 4,937

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Elevance Health Inc. net cash provided by operating activities increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Elevance Health Inc. net cash used in investing activities increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Elevance Health Inc. net cash provided by (used in) financing activities decreased from 2021 to 2022 and from 2022 to 2023.